1H-Pyrazolo[4,3-c]pyridine, 6-bromo-1-(tetrahydro-2H-pyran-2-yl)-
97%
- Product Code: 191111
CAS:
1416713-37-5
Molecular Weight: | 282.141 g./mol | Molecular Formula: | C₁₁H₁₂BrN₃O |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | 435.9±45.0 °C(Predicted) | |
Density: | 1.72±0.1 g/cm3(Predicted) | Storage Condition: | Room temperature |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors. Its structure supports the creation of bioactive molecules with potential applications in cancer therapy and inflammatory diseases. The bromo group allows for further functionalization via cross-coupling reactions, enabling rapid diversification in drug discovery programs. Commonly employed in research settings for building complex heterocyclic systems found in experimental therapeutics.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.100 G | 10-20 days | ฿3,090.00 |
+
-
|
1H-Pyrazolo[4,3-c]pyridine, 6-bromo-1-(tetrahydro-2H-pyran-2-yl)-
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors. Its structure supports the creation of bioactive molecules with potential applications in cancer therapy and inflammatory diseases. The bromo group allows for further functionalization via cross-coupling reactions, enabling rapid diversification in drug discovery programs. Commonly employed in research settings for building complex heterocyclic systems found in experimental therapeutics.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :